ProCE Banner Activity

Importance of Mixed Features and Anxious Distress Specifiers in the Care of Bipolar Depression

Clinical Thought

Explore the implications of mixed features and anxious distress specifiers for the prognosis and treatment of patients with bipolar depression. Definitions, diagnostic nuances, and clinical associations discussed in this brief commentary will be further explored in a live workshop series led by expert psychiatrists.

Released: June 07, 2024

Expiration: June 06, 2025

Share

Faculty

Roger S. McIntyre

Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
University of Toronto, Canada
Toronto, Canada

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc.

Disclosure

Primary Author

Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
University of Toronto, Canada
Toronto, Canada

Roger S. McIntyre, MD, FRCPC: speaker/consultant: AbbVie, Alkermes, Atai Life Sciences, Axsome, Bausch Health, Biogen, Boehringer Ingelheim, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, NeuraWell, Neurocrine, Novo Nordisk, NewBridge, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris; executive role: Braxia Scientific Corp.